Evaluation of Indigo carmine on hepatic ischemia and reperfusion injury by Eduardo Alexandre Rancan (10394206)

Epiduroscopy in spinal stenosis. Description of the procedure and safety measures to reduce complications by Eva M. Monzón (22208026)

Supplementary data for: Lack of Age-related Respiratory Changes in Daphnia by Lev Yampolsky (9644534)

InsR/FoxO1 Signaling Curtails Hypothalamic POMC Neuron Number by Leona Plum (27116)

Naturally emitted FS-1 and MS-1 pulses overlapped by continuous pure tones. by Andrej Čokl (302148)

“…<p><b>The relation between interference pulse duration and the difference between MS-1 and pure tone frequencies at different frequency and velocity levels</b>. a,b, c: naturally emitted FS-1 and MS-1 signals overlapped by (a) 100 Hz/0.69 mm/s, (b) 125 Hz/1.13 mm/s and (c) 150 Hz/0.60 mm/s pure tones. d: mean interference pulse duration (SD<40% of the mean value, N = 3–23, n = 6) of naturally emitted MS-1 signals overlapped by 100 Hz/0.22 mm/s (black diamonds), 125 Hz/0.22 mm/s (open squares) or 150 Hz/0.22 mm/s (grey triangles) pure tone vibration. …”

Experimental validation of the predicted temporal dynamics. by Tae J. Lee (241477)

“…The cell population treated with 0.3% serum exhibited a bimodal distribution of GFP at the 24th h . In contrast, a monomodal distribution was observed at 24th h in the cell population treated with 5% serum. …”

The extracellular matrix proteoglycan fibromodulin is upregulated in clinical and experimental heart failure and affects cardiac remodeling by Kine Andenæs (5566217)

“…Although collagen amount and cross-linking were comparable in FMOD-KO and wild-type, overexpression of fibromodulin in cardiac fibroblasts <i>in vitro</i> decreased their migratory capacity and expression of fibrosis-associated molecules, i.e. the collagen-cross linking enzyme lysyl oxidase, transglutaminase 2 and periostin. …”

Table_1_Medication guide for dose adjustment and management of cardiotoxicity and lipid metabolic adverse events of oral antineoplastic therapy.docx by Elena Ramos-Ruperez (16880154)

“…Eight OAAs (9.68%) have reported a decrease in LVEF, and four of these drugs, namely, encorafenib, lorlatinib, ripretinib, and sunitinib, have specific management recommendations. …”

Table2_Fire, volcanism and climate change: the main factors controlling mercury (Hg) accumulation rates in Tropical Lake Lantoa, Sulawesi, Indonesia (∼16,500–540 cal yr BP).xlsx... by Jalene Nalbant (17269828)

“…The Holocene Transition was marked by a decrease in HgAR (µ = 8, 3.50–18.84 μg m⁻² yr⁻¹) as humid conditions precluded forest burning, followed by high HgAR (µ = 11.35, 3.30–158.32 μg m⁻² yr⁻¹) in the Early Holocene. …”

Table1_Fire, volcanism and climate change: the main factors controlling mercury (Hg) accumulation rates in Tropical Lake Lantoa, Sulawesi, Indonesia (∼16,500–540 cal yr BP).xlsx... by Jalene Nalbant (17269828)

“…The Holocene Transition was marked by a decrease in HgAR (µ = 8, 3.50–18.84 μg m⁻² yr⁻¹) as humid conditions precluded forest burning, followed by high HgAR (µ = 11.35, 3.30–158.32 μg m⁻² yr⁻¹) in the Early Holocene. …”

Table3_Fire, volcanism and climate change: the main factors controlling mercury (Hg) accumulation rates in Tropical Lake Lantoa, Sulawesi, Indonesia (∼16,500–540 cal yr BP).xlsx... by Jalene Nalbant (17269828)

“…The Holocene Transition was marked by a decrease in HgAR (µ = 8, 3.50–18.84 μg m⁻² yr⁻¹) as humid conditions precluded forest burning, followed by high HgAR (µ = 11.35, 3.30–158.32 μg m⁻² yr⁻¹) in the Early Holocene. …”

Table4_Fire, volcanism and climate change: the main factors controlling mercury (Hg) accumulation rates in Tropical Lake Lantoa, Sulawesi, Indonesia (∼16,500–540 cal yr BP).xlsx... by Jalene Nalbant (17269828)

“…The Holocene Transition was marked by a decrease in HgAR (µ = 8, 3.50–18.84 μg m⁻² yr⁻¹) as humid conditions precluded forest burning, followed by high HgAR (µ = 11.35, 3.30–158.32 μg m⁻² yr⁻¹) in the Early Holocene. …”

Table_1_Long-Term Cardiac Safety and Survival Outcomes of Neoadjuvant Pegylated Liposomal Doxorubicin in Elderly Patients or Prone to Cardiotoxicity and Triple Negative Breast Canc... by Miguel J. Gil-Gil (3074085)

“…Most of tumors (88%) were triple negative. No significant decreases in LVEF were observed. The mean baseline LVEF was 66.6% (52-86) and after a median follow-up of 5 years, mean LVEF was 66 (54.5-73). …”

DataSheet_2_Long-Term Cardiac Safety and Survival Outcomes of Neoadjuvant Pegylated Liposomal Doxorubicin in Elderly Patients or Prone to Cardiotoxicity and Triple Negative Breast... by Miguel J. Gil-Gil (3074085)

“…Most of tumors (88%) were triple negative. No significant decreases in LVEF were observed. The mean baseline LVEF was 66.6% (52-86) and after a median follow-up of 5 years, mean LVEF was 66 (54.5-73). …”

Table_1_Long-Term Cardiac Safety and Survival Outcomes of Neoadjuvant Pegylated Liposomal Doxorubicin in Elderly Patients or Prone to Cardiotoxicity and Triple Negative Breast Canc... by Miguel J. Gil-Gil (3074085)

“…Most of tumors (88%) were triple negative. No significant decreases in LVEF were observed. The mean baseline LVEF was 66.6% (52-86) and after a median follow-up of 5 years, mean LVEF was 66 (54.5-73). …”

Table_2_Long-Term Cardiac Safety and Survival Outcomes of Neoadjuvant Pegylated Liposomal Doxorubicin in Elderly Patients or Prone to Cardiotoxicity and Triple Negative Breast Canc... by Miguel J. Gil-Gil (3074085)

“…Most of tumors (88%) were triple negative. No significant decreases in LVEF were observed. The mean baseline LVEF was 66.6% (52-86) and after a median follow-up of 5 years, mean LVEF was 66 (54.5-73). …”

DataSheet_2_Long-Term Cardiac Safety and Survival Outcomes of Neoadjuvant Pegylated Liposomal Doxorubicin in Elderly Patients or Prone to Cardiotoxicity and Triple Negative Breast... by Miguel J. Gil-Gil (3074085)

“…Most of tumors (88%) were triple negative. No significant decreases in LVEF were observed. The mean baseline LVEF was 66.6% (52-86) and after a median follow-up of 5 years, mean LVEF was 66 (54.5-73). …”

Table_3_Long-Term Cardiac Safety and Survival Outcomes of Neoadjuvant Pegylated Liposomal Doxorubicin in Elderly Patients or Prone to Cardiotoxicity and Triple Negative Breast Canc... by Miguel J. Gil-Gil (3074085)

“…Most of tumors (88%) were triple negative. No significant decreases in LVEF were observed. The mean baseline LVEF was 66.6% (52-86) and after a median follow-up of 5 years, mean LVEF was 66 (54.5-73). …”

Table_3_Long-Term Cardiac Safety and Survival Outcomes of Neoadjuvant Pegylated Liposomal Doxorubicin in Elderly Patients or Prone to Cardiotoxicity and Triple Negative Breast Canc... by Miguel J. Gil-Gil (3074085)

“…Most of tumors (88%) were triple negative. No significant decreases in LVEF were observed. The mean baseline LVEF was 66.6% (52-86) and after a median follow-up of 5 years, mean LVEF was 66 (54.5-73). …”

DataSheet_1_Long-Term Cardiac Safety and Survival Outcomes of Neoadjuvant Pegylated Liposomal Doxorubicin in Elderly Patients or Prone to Cardiotoxicity and Triple Negative Breast... by Miguel J. Gil-Gil (3074085)

“…Most of tumors (88%) were triple negative. No significant decreases in LVEF were observed. The mean baseline LVEF was 66.6% (52-86) and after a median follow-up of 5 years, mean LVEF was 66 (54.5-73). …”